GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 18.55
-0.05 (-0.27%)
May 8, 2026, 1:30 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 1.06 billion as of May 8, 2026. Its market cap has increased by 8.19% in one year.
Market Cap
1.06B
Enterprise Value
1.00B
Revenue
232.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.55
Market Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.06B, a decrease of -16.47%. That is a compound annual growth rate of -1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.06B | -2.01% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Preventive Medicine | 1.30B |
| Meribank Biotech | 1.25B |
| BiOptic | 1.13B |
| Holy Stone Healthcare | 1.11B |
| Level Biotechnology | 1.10B |
| LabTurbo Biotech | 1.06B |
| Lukas Biomedical | 1.06B |
| U-Neuron Biomedical | 1.04B |